Ohcanbohtosat - Robert Jenke

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives

    Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives Dahkki Robert Jenke, Nina Reßing, Finn K. Hansen, Achim Aigner, Thomas Büch

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer

    HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer Dahkki Robert Jenke, Denys Oliinyk, Tamara Zenz, Justus Körfer, Linda Schäker‐Hübner, Finn K. Hansen, Florian Lordick, Florian Meier-Rosar, Achim Aigner, Thomas Büch

    Almmustuhtton 2024
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors

    Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors Dahkki Linda Schäker‐Hübner, Reza Haschemi, Thomas Büch, Fabian B. Kraft, Birke Brumme, Andrea Schöler, Robert Jenke, Jens Meiler, Achim Aigner, Gerd Bendas, Finn K. Hansen

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: